MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12189-12200

  Tan, Xiang ^a   Chen, Mingwu ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Expression; GSEA; Meta analysis; MYL9; MYLK; QRT PCR; WB

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALMODULIN; CALMODULIN 1; CD123 ANTIGEN; CNAQ PROTEIN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 2 RECEPTOR BETA; COLONY STIMULATING FACTOR 3; GRIA2 PROTEIN; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 11 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 6 SIGNAL TRANSDUCER; LIFR PROTEIN; MESSENGER RNA; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN REGULATORY LIGHT CHAIN 9; PHOSPHOLIPASE C BETA4; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN; RAC PROTEIN; RAC3 PROTEIN; RHO ASSOCIATED PROTEIN KINASE 2; RHO KINASE; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; MYL9 PROTEIN, HUMAN; MYLK PROTEIN, HUMAN;

ARTICLE; BIOINFORMATICS; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOCAL ADHESION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; BIOLOGY; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; LUNG TUMOR; META ANALYSIS (TOPIC); METABOLISM; PATHOLOGY;

CALCIUM-BINDING PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LUNG NEOPLASMS; META-ANALYSIS AS TOPIC; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; SIGNAL TRANSDUCTION;

EID: 84925285494     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2527-3     Document Type: Article

References (46)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Gene Chromosome Cancer. 2013;52:356–69.
3. van Zandwijk N. New methods for early diagnosis of lung cancer. Lung Cancer. 2002;38:S9–11. Amsterdam, Netherlands.
4. Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP, et al. Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer. J Thorac Oncol. 2013;8:1148–55.
5. Rhodes DR, Chinnaiyan AM. Integrative analysis of the cancer transcriptome. Nat Genet. 2005;37(Suppl):S31–7.
6. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. Ncbi geo: mining tens of millions of expression profiles—database and tools update. Nucleic Acids Res. 2007;35:D760–5.
7. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50.
8. Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A, et al. Notch1 directly regulates c-myc and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006;103:18261–6.
9. Greenbaum D, Jansen R, Gerstein M. Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics. 2002;18:585–96. Oxford, England.
10. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
11. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–64. Oxford, England.
12. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy—analysis of Affymetrix Genechip data at the probe level. Bioinformatics. 2004;20:307–15. Oxford, England.
13. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
14. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3, Article3.
15. Daves MH, Hilsenbeck SG, Lau CC, Man TK. Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Med Genet. 2011;4:56.
16. Chen ZJ, Le HB, Zhang YK, Qian LY, Li WD. Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features. J Int Med Res. 2009;37:551–6.
17. Oshika Y, Masuda K, Tokunaga T, Hatanaka H, Kamiya T, Abe Y, et al. Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res. 1998;4:1785–8.
18. Chen ZL, Zhao SH, Wang Z, Qiu B, Li BZ, Zhou F, et al. Expression and unique functions of four nuclear factor of activated T cells isoforms in non-small cell lung cancer. Chin J Cancer. 2011;30:62–8.
19. Ivanova M, Abner S, Pierce Jr W, Klinge C. Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses. Proteome Sci. 2011;9:60.
20. Choi YJ, Kim ST, Park KH, Oh SC, Seo JH, Shin SW, et al. The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients. Med Oncol. 2012;29:582–8. Northwood, London, England.
21. Bieniasz M, Oszajca K, Eusebio M, Kordiak J, Bartkowiak J, Szemraj J. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer. 2009;66:319–26. Amsterdam, Netherlands.
22. Langenfeld EM, Bojnowski J, Perone J, Langenfeld J. Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg. 2005;80:1028–32.
23. McKeown DJ, Brown DJ, Kelly A, Wallace AM, McMillan DC. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer. Br J Cancer. 2004;91:1993–5.
24. Haura EB, Livingston S, Coppola D. Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer. Clin Lung Cancer. 2006;7:273–5.
25. Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, et al. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components. Cell Growth Differ. 1996;7:923–9.
26. Oshika Y, Nakamura M, Hatanaka H, Abe Y, Tokunaga T, Ohnishi Y, et al. A human lung cancer xenograft producing granulocyte-colony stimulating factor and parathyroid hormone-related protein. Oncol Rep. 1998;5:359–62.
27. Liu P, Morrison C, Wang L, Xiong D, Vedell P, Cui P, et al. Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. 2012;33:1270–6.
28. Minamiya Y, Nakagawa T, Saito H, Matsuzaki I, Taguchi K, Ito M, et al. Increased expression of myosin light chain kinase mRNA is related to metastasis in non-small cell lung cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2005;26:153–7.
29. MacDonald JW, Ghosh D. COPA—cancer outlier profile analysis. Bioinformatics. 2006;22:2950–1. Oxford, England.
30. Fang X, Netzer M, Baumgartner C, Bai C, Wang X. Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer. Cancer Treat Rev. 2013;39:77–88.
31. Lazar V, Garcia JG. A single human myosin light chain kinase gene (MLCK; MYLK). Genomics. 1999;57:256–67.
32. Somlyo AP, Somlyo AV. Signal transduction by g-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin ii. J Physiol. 2000;522(Pt 2):177–85.
33. 2+ sensitivity of smooth muscle and nonmuscle myosin ii: modulated by g proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83:1325–58.
34. Bresnick AR. Molecular mechanisms of nonmuscle myosin-ii regulation. Curr Opin Cell Biol. 1999;11:26–33.
35. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem. 2001;276:4527–30.
36. Shehadeh LA, Webster KA, Hare JM, Vazquez-Padron RI. Dynamic regulation of vascular myosin light chain (MYL9) with injury and aging. PLoS ONE. 2011;6:e25855.
37. Hu W, Feng P. Myosin light chain kinase is involved in the mechanism of gastrointestinal dysfunction in diabetic rats. Dig Dis Sci. 2012;57:1197–202.
38. Han YJ, Ma SF, Yourek G, Park YD, Garcia JG. A transcribed pseudogene of MYLK promotes cell proliferation. FASEB J. 2011;25:2305–12.
39. Lee WS, Seo G, Shin HJ, Yun SH, Yun H, Choi N, et al. Identification of differentially expressed genes in microsatellite stable hnpcc and sporadic colon cancer. J Surg Res. 2008;144:29–35.
40. Chen L, Su L, Li J, Zheng Y, Yu B, Yu Y, et al. Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer. Dis Markers. 2012;32:195–202.
41. Coniglio SJ, Zavarella S, Symons MH. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol. 2008;28:4162–72.
42. Fincham VJ, James M, Frame MC, Winder SJ. Active ERK/MAP kinase is targeted to newly forming cell-matrix adhesions by integrin engagement and v-Src. EMBO J. 2000;19:2911–23.
43. Ren K, Jin H, Bian C, He H, Liu X, Zhang S, et al. MR-1 modulates proliferation and migration of human hepatoma HepG2 cells through myosin light chains-2 (MLC2)/focal adhesion kinase (FAK)/Akt signaling pathway. J Biol Chem. 2008;283:35598–605.
44. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 2004;14:241–9.
45. Berridge MJ. Smooth muscle cell calcium activation mechanisms. J Physiol. 2008;586:5047–61.
46. Zhou X, Liu Y, You J, Zhang H, Zhang X, Ye L. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett. 2008;270:312–27.